Associations of depression with impaired glucose regulation, newly diagnosed diabetes and previously diagnosed diabetes in Chinese adults
Jichao Sun(MacroGenics (United States)), Yiming Mu(Chinese PLA General Hospital), Yanni Wang(Zhejiang Chinese Medical University), Zuojie Luo(Guangxi Medical University), Y. Liu(Jilin University), Xuefeng Yu(Dalian University of Technology), Yan Bi(National Clinical Research Center for Digestive Diseases), Lixin Shi(Guizhou University), W. Q. Wang(Shanghai Jiao Tong University), Xulei Tang(Lanzhou University of Technology), Jie Lü(Qingdao University), DongDong Li(The University of Texas MD Anderson Cancer Center), Liebin Zhao(United Imaging Healthcare (China)), Shenghan Lai(University of Maryland, Baltimore), Guang Ning(Shanghai Jiao Tong University), Ting-gang Wang(Shanghai Jiao Tong University), Feixia Shen(Wenzhou Medical University), Guijun Qin(First Affiliated Hospital of Zhengzhou University), Leyan Chen(Qilu Hospital of Shandong University), Q. Li(Qinhuangdao Second Hospital), G. X. Wang(Jilin University), Qing Su(Shanghai Jiao Tong University), Zhengnan Gao(Dalian University of Foreign Languages), Gang Chen(Fujian Medical University), Lulu Chen(Zunyi Medical University), S. L. Wu(University of Wisconsin–Madison), Qin Wan(First Affiliated Hospital of Sichuan Medical University), Li Yan(Sun Yat-sen University), Zhen Ye(Fudan University), Tao Yang(Jiangsu Province Hospital), Chao Liu(China Pharmaceutical University), Yanan Huo(Jiangxi Provincial People's Hospital), Mao Xu(Shanghai Jiao Tong University), Jiajun Zhao(Shandong Provincial Hospital), Huacong Deng(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 40
Related Papers
Experimental Observation of a Heavy Particle<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi>J</mml:mi></mml:math>
|Physical Review Letters|1974|1.6k
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
|New England Journal of Medicine|2022|227